27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Sanofi SA (ADR) (NYSE:SNY), is approaching a growth inflection point, according to Bank of America Merrill Lynch. The sell-side firm is projecting 6-percent earnings per share growth for the pharmaceutical company.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Analyst Graham Parry upgraded Sanofi from Neutral to Buy and raised the price target from $80 to $95.
The Thesis
Parry considers the combination of new products, consumer health and vaccines as having the ability to balance out the "diminishing heawind of diabetes." (See his track record here.)
The analyst said he has growing confidence in the following growth drivers for Sanofi:
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
- Dupixent's strong launch in dermatitis.
- Expectations of 4-percent consumer growth in 2019.
- A recovery in vaccines this year on the basis of a resolution of manufacturing issues in China.
“We expect diabetes to become less of a headwind into 2019 and beyond, declining 6-percent [in 2019] vs. 13 percent in 2017-18," Parry said.
"Although price pressure for U.S. Lantus has not abated, additional biosimilars may launch [in] 2019/20, and we continue to forecast 20-30-percent year-over-year sales declines going forwards, it now only represents 3 percent of 2019 group sales vs. 13 percent in 2014. We expect growth in other regions [and] products to increasingly offset."
Price Action
Sanofi shares were up 1.2 percent at $42.60 before the close Monday.
Related Links:
Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy
Morgan Stanley Downgrades Jazz Pharmaceuticals As Stock Approaches Price Target
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.